Effects of Microcirculation-assisted Adjustment of Blood Flow of VA-ECMO on Prognosis
Study Details
Study Description
Brief Summary
One of the key factors of survival of patients with extra-corporeal membrane oxygenation (ECMO) life support system is whether the blood flow supplied by ECMO can meet the need of perfusion of each organ. In our previous study, we found that microcirculaton parameters within 12h after placement of venoarterial ECMO (VA-ECMO) were lower in the 28-day non-survivors than those in the survivors. Moreover, in our ongoing observational clinical trial, we found that adjustment of ECMO blood flow could improve microcirculatory dysfunction in some patients. We hypothesize that if we can find out the patients with poor microcirculation and use the microcirculation parameters to assist the adjustment of ECMO blood flow and related treatments, we might improve the survival of these patients. In this clinical trial, the patients will receive microcirculation examination within 18h after placement of ECMO. The patients were randomly divided into control and microcirculation-assisted groups. The microcirculation parameters in patients of the microcirculation-assisted group will be given to the ECMO team, and the ECMO blood flow and relative treatments will be adjusted according to macrocirculation parameters, clinical condition, and microcirculation parameters. In the patients of the control group, the ECMO blood flow and related treatments will be adjusted according to macrocirculation parameters and clinical condition. The microcirculation will be measured twice after T1, and the ECMO and related treatments will be adjusted as previous description. The microcirculation will be measured at 72h after placement of VA-ECMO. The ECMO setting, intake-output balance, dose of inotropic and vasopressors, and prognosis will be recorded. The difference will be compared between the two groups.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
For severe cardiac and respiratory failure patients, extra-corporeal membrane oxygenation (ECMO) life support system can help them to have time to wait for the recovery of cardiac and respiratory function or receiving advanced managements. One of the key factors of survival is whether the blood flow supplied by ECMO can meet the need of perfusion of each organ. In our previous study, we found that perfused small vessel density and proportion of perfused small vessel within 18h after placement of venoarterial ECMO (VA-ECMO) were lower in the 28-day non-survivors than those in the survivors. In one research of goal-directed treatment of septic shock, it shows that early microcirculation improved more in the patients with mild organ failure at 24h than in the patients with severe organ failure at 24h. Moreover, in our ongoing observational clinical trial, we found that adjustment of ECMO blood flow could improve microcirculatory dysfunction in some patients. We hypothesize that if we can find out the patients with poor microcirculation and use the microcirculation parameters to assist the adjustment of ECMO blood flow and related treatments, we might improve the survival of these patients. In this clinical trial, the patients will receive microcirculation examination within 18h (T1) after placement of ECMO. The patients were randomly divided into control and microcirculation-assisted groups. The microcirculation parameters in patients of the microcirculation-assisted group will be given to the ECMO team, and the ECMO blood flow and relative treatments will be adjusted according to macrocirculation parameters, clinical condition, and microcirculation parameters. In the patients of the control group, the ECMO blood flow and related treatments will be adjusted according to macrocirculation parameters and clinical condition. The microcirculation will be measured again at 6-22h after T1 and 28-44h after T1, and the ECMO and related treatments will be adjusted as previous description. The microcirculation will be measured at 72h after placement of VA-ECMO. The ECMO setting, intake-output balance, dose of inotropic and vasopressors, and prognosis will be recorded. The difference will be compared between the two groups.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Microcirculation-assisted ECMO blood flow will be adjusted by conventional clinical conditions, hemodynamic parameters and microcirculation parameters |
Device: Microcirculation examination
Sublingual microcirculation images were recorded using an incident dark-field video microscope
|
| Active Comparator: Control ECMO blood flow will be adjusted by clinical conditions and conventional hemodynamic parameters |
Device: Microcirculation examination
Sublingual microcirculation images were recorded using an incident dark-field video microscope
|
Outcome Measures
Primary Outcome Measures
- Lactate [24h]
The difference of lactate level between Microcirculation-assisted group and control group
Secondary Outcome Measures
- Lactate [48h]
The difference of lactate level between Microcirculation-assisted group and control group
- Lactate [72h]
The difference of lactate level between Microcirculation-assisted group and control group
- perfused small vessel density [24h]
The difference of perfused small vessel density between Microcirculation-assisted group and control group
- perfused small vessel density [48h]
The difference of perfused small vessel density between Microcirculation-assisted group and control group
- perfused small vessel density [72h]
The difference of perfused small vessel density between Microcirculation-assisted group and control group
- endocan level [24h]
The difference of endocan level between Microcirculation-assisted group and control group
- diamine oxidase level [24h]
The difference of diamine oxidase level between Microcirculation-assisted group and control group
- inotropic score [24h]
The difference of inotropic score between Microcirculation-assisted group and control group
Eligibility Criteria
Criteria
Inclusion Criteria:
- patients with venoarterial extra-corporeal membrane oxygenation
Exclusion Criteria:
-
unable to receive microcirculation within 18 hours after placement of venoarterial extra-corporeal membrane oxygenation
-
non-native speakers and family
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Taiwan University Hospital | Taipei | Taiwan | 100 |
Sponsors and Collaborators
- National Taiwan University Hospital
Investigators
- Principal Investigator: Yu-Chang Yeh, MD, PhD, National Taiwan University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 201712044RINC